Trinity Biotech Plc ADR (TRIB) concluded trading on Wednesday at a closing price of $0.59, with 22.59 million shares of worth about $13.33 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -37.90% during that period and on Wednesday, January 31 the price saw a gain of about 35.66%. Currently the company’s common shares owned by public are about 38.11M shares, out of which, 35.71M shares are available for trading.
Stock saw a price change of 43.90% in past 5 days and over the past one month there was a price change of 37.53%. Year-to-date (YTD), TRIB shares are showing a performance of 37.53% which decreased to -46.84% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.37 but also hit the highest price of $1.24 during that period. The average intraday trading volume for Trinity Biotech Plc ADR shares is 49.36K. The stock is currently trading 30.29% above its 20-day simple moving average (SMA20), while that difference is up 30.26% for SMA50 and it goes to -17.95% lower than SMA200.
Trinity Biotech Plc ADR (NASDAQ: TRIB) currently have 38.11M outstanding shares and institutions hold larger chunk of about 16.05% of that.
The stock has a current market capitalization of $22.54M and its 3Y-monthly beta is at 1.30. It has posted earnings per share of -$0.75 in the same period. It has Quick Ratio of 1.80. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TRIB, volatility over the week remained 12.23% while standing at 12.50% over the month.
Analysts are in expectations that Trinity Biotech Plc ADR (TRIB) stock would likely to be making an EPS of -$0.15 in the current quarter, while forecast for next quarter EPS is -$0.14 and it is -$0.3 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.15 which is -$0.15 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.23 in the same quarter a year ago. EPS is likely to grow at an annualized rate of 15.00% for next 5-years, compared to annual growth of 8.35% made by the stock over the past 5-years.
